Caelus Health's Series A Round

Caelus Health raised a round of funding on February 02, 2017. Investors include Johnson & Johnson.

Caelus Health is an Amsterdam-based biotech company developing an entirely new class of Microbiome Therapeutics for the reduction of insulin resistance and prevention of Type 2 Diabetes (T2DM) in peop…

Articles about Caelus Health's Series A Round: